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Abstract
Background: The M-like protein, also known as SzP, is expressed on the surface of Streptococcus
equi subsp. zooepidemicus (S. zooepidemicus). Previous studies demonstrated that SzP is similar to M
protein of group A Streptococcus in the structure and characteristics of antiphagocytosis. The M
protein is an adhesin that can bind to the host cells, however it is not known whether the SzP of
S. zooepidemicus also functions as an adhesin. We conducted an investigation to determine SzP as
an adhesin, and one SzP epitope was identified to be responsible for mediating binding to HEp-2
cells.
Methods: The gene encoding SzP was expressed in E. coli, and the purified recombinant SzP (rSzP)
was recognized by rabbit anti-S. zooepidemicus antibodies using immunoblot. Furthermore, the
adherence of S. zooepidemicus to HEp-2 cells was inhibited by anti-rSzP antibodies in a dose-
dependent manner. We employed a random 12-peptide phage display library for screening of
immunodominant mimics of the SzP, which were recognized by an anti-SzP specific monoclonal
antibody (mAb 2C8). Initial positive phage clones were identified by ELISA, followed by assays to
determine the adherence-inhibiting ability of the peptide.
Results: Ten out of fourteen selected positive clones showed high reactivity that effectively
inhibited the binding of mAb 2C8 to rSzP. The motif XSLSRX was highly conserved among six of
the ten clones.
Conclusion:  Collectively, our findings suggest that the motif XSLSRX may represent an
immunodominant mimic epitope of the SzP of S. zooepidemicus strain ATCC 35246, and that the
same epitope may be used to mediate SzP binding to HEp-2 cells.
Background
Streptococcus equi subsp. zooepidemicus (S. zooepidemicus),
which belongs to Lancefield group C streptococci, is an
important animal pathogen, especially in horse [1]. It has
a broad host spectrum and occasionally infects humans.
Human infections may occur following ingestion of
unpasteurized milk or dairy products [2], or after contact
with pigs [3]. In China, S. zooepidemicus is the main pig
pathogen. In the summer of 1975, a S. zooepidemicus dis-
ease outbreak occurred among pigs in the Sichuan prov-
ince, China. Clinical symptoms of the diseased pigs
included painful swelling of the joints, respiratory distur-
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bances, and diarrhea. More than 300,000 pigs died within
two weeks. According to bacteriological examinations, S.
zooepidemicus was isolated from most of the diseased pigs,
and it appeared to be one of the major causative agents
[4].
M protein is an important virulence factor of group A
streptococci: this fibrillar, surface-exposed protein deters
opsonization of the organism using the alternate comple-
ment pathway [5,6]. Strains of group A streptococci
expressing M protein are resistant to phagocytosis by
human polymorphonuclear leukocytes, whereas strains
that fail to express M protein are avirulent [7]. Previous
studies demonstrated that S. zooepidemicus carry antigens
with characteristics of the antiphagocytic M protein of the
Lancefield group A and G streptococci; it was named M-
like protein (SzP) [8]. Cloning of the gene encoding SzP
from an equine strain of subsp. zooepidemicus revealed a
single open reading frame of 1,128 bp [9], whereas the
SzP gene (GenBank accession number: AY263781) from a
pig strain of subsp. zooepidemicus showed a single open
reading frame of 1,137 bp (GenBank accession number:
U04620) [10].
Similar to other streptococcal species, S.  zooepidemicus
binds to a number of host proteins, including immu-
noglobulin G [11], serum albumin [12], fibronectin, col-
lagen [13], and α-macro-globulin [14] through cell
surface components. These host-parasite recognition
components may function as virulence factors by acting as
adhesions or antiopsonins. Bacterial adhesion to the host
cell is the first step in bacterial infection. The M protein of
streptococcus group A is an adhesin that can bind to the
host cell, however it is not known whether the SzP of S.
zooepidemicus also functions as an adhesion, and the adhe-
sion mechanism of SzP binding to host cell is unclear.
Here, we report the adhesive function of the SzP to human
HEp-2 epithelial cells. Furthermore, we identified several
immunodominant mimic epitopes of SzP using random
peptide phage library in combination with ELISA and
binding-inhibition assays. Alignment of the phage display
peptides yielded a conserved motif, XSLSRX, which repre-
sents an immunodominant mimic epitope of the SzP of S.
zooepidemicus strain ATCC 35246 and may mediate bind-
ing to HEp-2 cells.
Results
Molecular characterization of M-like protein
Nucleotide sequence analysis revealed a single open read-
ing frame in the szp gene of S. zooepidemicus ATCC 35246
isolated from pigs; translation of this open reading frame
revealed a protein of 379 amino acids. The szp  gene
showed 86.9% homology at the nucleotide level with the
szp gene of S. zooepidemicus W60 strain isolated from the
horse, and 29.4% homology with the M protein gene of
group A streptococci [10]. Expression of the mature szp
gene under the control of the T7 promoter sequence was
achieved with high yield and purity (Fig. 1). SDS-PAGE
analysis demonstrated that the recombinant protein was
60 kDa, and was confirmed to be SzP by immunoblot
analysis using rabbit anti- S. zooepidemicus antibody.
Binding of rSzP to HEp-2 host cells
The binding of purified rSzP to HEp-2 monolayers was
assessed by ELISA. Purified rSzP exhibited significant,
dose-dependent binding to HEp-2 cells, whereas binding
of the negative control, fetuin, was negligible (Fig. 2A and
2B). Adherence inhibition assays were used to determine
the ability of anti-SzP antibodies to inhibit adherence of
S. zooepidemicus to HEp-2 cells. Biotinylated S. zooepidem-
icus intact cells were first pretreated with the anti- SzP pol-
yclonal/monoclonal antibodies and were then tested for
the ability to bind HEp-2 monolayers. Pretreatment of
biotinylated S. zooepidemicus with increasing amounts of
anti- SzP polyclonal antibodies resulted in a significant (P
< 0.01) dose-dependent inhibition of bacterial adherence
(23%, 48%, and 58% reduction at 1:1,000, 1:100, and
1:10 dilutions, respectively) (Fig. 2C). No significant dif-
ference (P > 0.05) was observed in the adherence of nor-
mal serum-treated bacteria to HEp-2 cells (Fig. 2D). Out
of the 12 monoclonal antibodies,only 2C8 was able to
SDS-PAGE analysis and western blot of rSzP Figure 1
SDS-PAGE analysis and western blot of rSzP. Lane 1, 
Marker. Lane 2, E. coli BL21 (DE3) pLysS after IPTG induc-
tion. Lane 3, E. coli BL21 (DE3) pLysS before IPTG induction. 
Lane 4, Reactivity of purified rSzP with rabbit anti-S. zooepi-
demicus antibody.BMC Microbiology 2008, 8:170 http://www.biomedcentral.com/1471-2180/8/170
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Characterization of purified rSzP protein binding to HEp-2 cells by ELISA Figure 2
Characterization of purified rSzP protein binding to HEp-2 cells by ELISA. (A) Binding of biotinylated S. zooepidem-
icus whole cells, rSzP protein, and a fetuin control to HEp-2 monolayers. (B) Dose-dependent binding of rSzP to HEp-2 cells. 
(C) Inhibition of S. zooepidemicus binding to HEp-2 monolayers following pretreatment of bacteria with rabbit polyclonal anti-
SzP antibodies. (D) No inhibition of HEp-2 binding with control rabbit serum. (E) Inhibition of S. zooepidemicus binding to HEp-
2 monolayers following pretreatment of bacteria with monoclonal antibodies against SzP. For all experiments, absorbance val-
ues are means from representative experiments performed in triplicate. Error bars show the range of absorbance values.BMC Microbiology 2008, 8:170 http://www.biomedcentral.com/1471-2180/8/170
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inhibit the adherence of S. zooepidemicus to HEp-2 cells
(Fig. 2E).
Biopanning
The anti-SzP monoclonal antibody 2C8 was immobilized
onto microtiter wells to pan mimic epitopes from random
12-mer peptides library during five successive rounds of
selection. The productivities of the target phages for the
first and the fifth biopanning were 1.71 × 10-6 and 3.39 ×
10-6, respectively, and false positive rates were reduced
from 0.203 to 2.2 × 10-3, respectively. Taken together,
these values indicate a significant enrichment of the
selected phages.
Specificity analysis
ELISA was used to confirm that the phage-displayed pep-
tides were specifically recognized by mAb 2C8; normal
antiserum was used as a negative control. A phage was
considered to be specifically bound by mAb 2C8 when
(Aa:Ab) > 0.3, where Aa and Ab correspond to the absorb-
ance of the phage binding to 2C8 mAb and normal antise-
rum, respectively. Based on these criteria, 14 phage
colonies were positive in a sandwich ELISA assay (Fig. 3)
and were propagated for inhibition experiments.
Inhibition experiments
Competitive inhibition experiments were performed to
determine whether the selected phages contained the
same or mimic epitopes of the SzP. The results showed
that ten of the fourteen clones (P3, P4, P5, P6, P8, P9, P11,
P12, P13, and P14) displayed an inhibition level of
greater than 40% by mAb 2C8 (Fig. 4). These results dem-
onstrated that each selected phage contained a binding
site to the mAb, that the binding sites of the phage-dis-
played peptides are SzP-specific, and that they may func-
tion as immunodominant mimics of the SzP (Fig. 4).
Characterization of positive selected phage clones
Ten phages that showed specific binding were selected
from an initial 14 phages and sent for sequencing.
Sequencing of the phage inserts revealed that four out of
the 10 phages displayed KSLSRHDHIHHH, one phage
displayed SSLSRGKPSRP, one phage displayed
SSLSPQRHSYPA, and only one phage (P11) showed no
similarity to either peptide sequence (Table 1). Alignment
using the DNAStar-MegAlign software showed that the
motif XSLSRX was conserved among them.
Discussion
M protein is composed of two predominantly alpha-heli-
cal protein chains assembled in a coiled-coil that extends
ELISA reactivities of 14 phage clones (P1–P14) with mAb 2C8 and normal antiserum Figure 3
ELISA reactivities of 14 phage clones (P1–P14) with mAb 2C8 and normal antiserum. ELISA experiments are 
described in the Materials and Methods. In all experiments, absorbance values are means from representative experiments per-
formed in triplicate. Error bars show the range of absorbance values.BMC Microbiology 2008, 8:170 http://www.biomedcentral.com/1471-2180/8/170
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from the bacterial cell surface [15]. The M protein C termi-
nus, which is anchored to the cell membrane and traverses
the cell wall, is highly conserved, whereas the N terminus,
which contacts the external environment, is highly varia-
ble and accounts for the type specificity. There are more
than 100 known M protein serotypes of group A strepto-
cocci, and the serotype specificity is largely determined by
epitopes located in the N-terminal 40 to 50 residues [16-
19]. SzP is similar in structure to M protein of group A
streptococci. In addition to S. zooepidemicus, SzP have also
been detected in other group C and G streptococci
[10,20,21]. SzP elicited protective antibodies and
impaired deposition of C3 on the bacterial surface [9]. szp
gene has also been cloned from S. zooepidemicus [9,10].
The predicted amino acid structure contains an alpha-hel-
ical repeat and shows highly homology to the C terminus
of M proteins of group A, however the extensive A, B, C
repeat regions found in M proteins of group A are absent.
When compared to the SzP of S. zooepidemicus  equine
strain W60, the following N-terminal residues differ:
S27G, S28V, V30A, and A32S; all of the swine strains
shared the same signal peptide. The C terminus of SzP of
S. zooepidemicus is rich in proline residues, and is com-
posed primarily of PEPK repeats. The known swine strains
shared 11 PEPK repeats with the SzP, whereas the equine
strain W60 shared only 10 PEPK repeats [9,22].
Bacterial attachment to a host tissue is often the first step
leading to colonization and the development of an infec-
tious disease. The bacteria are dependent on their own
surface components, called "adhesins", for binding in a
stereochemical manner to complementary molecules on
the host tissue surface. Most bacterial adhesins are pro-
teins, and they are frequently contained in filamentous
surface appendages known as fimbriae or pili [23,24].
Streptococcal survival in the host depends on the M pro-
Inhibition assays of 14 phage clones (P1–P14) with rSzP Figure 4
Inhibition assays of 14 phage clones (P1–P14) with rSzP. Inhibition of phage binding to mAb was detected by ELISA as 
described in Section 2. For each phage, binding of phage to mAb was inhibited by rSzP. Average values (A450 nm) from three 
independent experiments have been determined. Results are expressed as the difference between the average value of non-
inhibition and that of inhibition.
Table 1: Inserts of phage clones from the fifth round of panning 
with mAb 2C8.
Clone number Peptide sequence Frequency
P3, P4, P8, P13 KSLSRHDHIHHH 4
P14 SSLSRGKPSPRP 1
P6 PSLSRQRHSYPA 1
P5 GTVLPDLSRNPY 1
P9 TWLTPSFPFYLG 1
P12 TPLDRGTWLFTK 1
P11 NTFNEFWPSNSW 1BMC Microbiology 2008, 8:170 http://www.biomedcentral.com/1471-2180/8/170
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tein, which protects the bacterium from phagocytosis by
polymorphonuclear leukocytes [7]. Bacterial strains that
express high levels of M protein have been reported to
adhere to human epithelial cells in significantly higher
numbers than M protein-deficient strains, suggesting that
this molecule also plays a critical role in adherence to
human tissue [25]. The present study has shown that rSzP
can attach to HEp-2 cells in a manner inhibited by both
anti-rSzP antibodies and by anti-S. zooepidemicus antibod-
ies, suggesting that the SzP is a putative adhesin of S.
zooepidemicus, which may contribute to the colonization
in vivo.
Recent investigations have successfully employed phage
display libraries to identify specific ligands for antibodies,
enzymes, cell surface receptors, drugs, and epitopes [26-
28]. Furthermore, studies have demonstrated that some
selected ligands do not necessarily resemble the natural
ligand, but instead mimic their binding properties [29]. In
view of this, peptide phage libraries may be used as a rapid
and convenient method for selecting "novel" peptide
epitopes regardless of whether their displayed peptide
sequences are homologous to the natural antigen, and
may thereby serve as ideal candidates in vaccine develop-
ment [27]. The potential for use of random peptide phage
display libraries in defining specificities of mAbs has been
demonstrated successfully [28]. In the present study, fol-
lowing five rounds of enrichment, 14 positive phage
clones had higher binding capacity, indicating that the lig-
ands had been selected successfully. Inhibition assays
were used to assess whether ligands obtained in this study
mimicked the SzP. Results showed that 10 phage clones
effectively inhibited mAb 2C8 binding to rSzP. The motif
XSLSRX was identified as highly conserved among these
peptides. We believe that these findings will be helpful in
clarifying the pathogenic mechanism of S. zooepidemicus.
However, we did not find similar motifs in the SzP. Thus,
the XSLSRX motif might act as a mimic epitope. Future
studies are needed to address whether the XSLSRX epitope
may be discontinuous.
Conclusion
The investigation provided strong evidence that the M-like
protein of Streptococcus equi subsp.  zooepidemicus  strain
ATCC 35246 was an adhesin. The motif XSLSRX may rep-
resent an immunodominant mimic epitope of M-like pro-
tein, and that the same epitope may be used to mediate M-
like protein binding to HEp-2 cells.
Methods
Bacterial strains, plasmids, and growth conditions
S. zooepidemicus strain ATCC 35246 was isolated from a
diseased pig in Sichuan province in 1975 and was stored
at -70°C in Todd-Hewitt broth (THB). The strain was
grown on Todd-Hewitt agar plates supplemented with 5%
sheep blood at 37°C. Escherichia coli strain BL21 (DE3)
pLysS was grown in Luria-Bertani broth. The PET32a(+)
vector was used for subcloning and protein expression.
S. zooepidemicus M-like protein expression and 
purification
The mature szp gene of ATCC 35246 (without the putative
promoter or leader signal peptide) was directionally sub-
cloned downstream of an isopropyl β-D-1-thiogalacto-
pyranoside (IPTG)-inducible T7/lac  promoter, and the
start codon (ATG) of the PET32a(+) expression vector was
used to produce recombinant SzP (rSzP). The resulting
plasmid was then used to transform competent E. coli
BL21 (DE3) pLysS as described previously [15]. Expres-
sion was induced by the addition of IPTG, and the fusion
protein was purified using a nickel-loaded affinity chelate
resin purification system (Tosoh Biosep, Montgomery-
ville, PA, USA) according to the manufacturer's instruc-
tions.
Expression of rSzP was determined by sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
analysis using whole-cell lysates before and after IPTG
induction. Immunoblot analysis was performed as
described previously [16] to determine whether the rSzP
protein was recognized by antiserum against S. zooepidem-
icus.
Preparation and characterization of monoclonal 
antibodies
Briefly, BALB/c mice were intraperitoneally immunized
twice (on days 1 and 14) with 20 μg of purified rM-like
protein (10 μg each), first in complete adjuvant and then
in incomplete Freund's adjuvant. Two weeks after the sec-
ond immunization, the mice were boosted intraperito-
neally with 5 μg of purified rSzP protein in phosphate-
buffered saline (PBS). Spleens from the mice were col-
lected 3 days after the boost and were used for fusion with
SP2/0 myeloma cells following a standard polyethylene-
glycol-mediated cell fusion procedure. Hybridomas
secreting antibodies were screened by an in-house S.
zooepidemicus-specific indirect ELISA, and the positives
were cloned by limiting dilution,ELISA tests were per-
formed as described previously [17]. Twelve SzP-specific
mAbs, including F4, F5, F6, 611, 613, 621, 622, 623, 1D4,
2C8, 3F4, and 5E6 were obtained. Their immunoglobulin
subclasses were determined using a subtyping kit (Pierce
Biotechnology, Rockford, USA), and were IgG1 for F4,
611, 613, 623, 2C8, and 3F4, IgG2b for F6, 621, 622, and
5E6, and IgM for F5 and 1D4. Competitive ELISA revealed
that the twelve mAbs recognized spatially independent
epitopes. The mAbs in ascites fluids were purified by satu-
rated ammonia sulfate precipitation and DEAE-cellulose
chromatography as described previously [17].BMC Microbiology 2008, 8:170 http://www.biomedcentral.com/1471-2180/8/170
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Preparation of polyclonal antibodies
Polyclonal antibodies (pAb) against SzP were prepared
using 2-month-old New Zealand rabbits. Rabbits were
first injected subcutaneously in three sites with a total of 2
ml emulsified mixture (PBS containing 200 μg of purified
protein) and complete Freund's adjuvant (Sigma, St.
Louis, MO, USA). Booster inoculations were given at
biweekly intervals in an identical manner, except incom-
plete Freund's adjuvant (Sigma, St. Louis, MO, USA) was
used. Blood was drawn at each boost for antibody moni-
toring. When the serum anti-SzP titer reached 1:10,000 as
measured by indirect ELISA, rabbits were sacrificed by car-
diac exsanguinations, and antiserum was prepared. IgG
from the rabbit antiserum was purified by saturated
ammonia sulfate precipitation and DEAE-cellulose chro-
matography. At the same time, anti-serum against S.
zooepidemicus was prepared as described above.
Binding of purified rSzP to HEp-2 cells
Binding tests were performed as described [18]. Briefly,
HEp-2 cells were seeded (1.4 × 104 cells/well) in growth
medium containing 10% fetal bovine serum (ATCC) in
microtiter wells precoated with 0.2% gelatin and were
grown to confluence in a humidified atmosphere at 37°C
with 5% CO2. The following day, the seeded wells were
washed three times with fetal calf serum-free M1640
medium, and either live S. zooepidemicus (1.4 × 105 cells/
well), purified rSzP, or a fetuin control (3 μg/well) diluted
in M1640 medium was added to the wells and incubated
for 4 h in a humidified atmosphere at 37°C with 5% CO2.
The plates were washed three times as indicated above
and were fixed in 20% acetone (150 μl) for 10 min at
room temperature. Excess acetone was removed from the
wells, and the plates were allowed to dry at 37°C over-
night. For immunoassays, the acetone-fixed cells were
probed with rabbit anti-S. zooepidemicus, rabbit anti- rSzP,
or rabbit anti-fetuin (Sigma, St. Louis, MO, USA; 1:1,600)
diluted in PBS containing 0.5% Tween-20 (PBS-T), fol-
lowed by incubation with horseradish peroxidase (HRP)-
conjugated goat anti-rabbit IgG (Sigma, St. Louis, MO,
USA; 1:8,000 diluted in PBS-T). Negative controls were
used in all experiments and included wells containing
only cells and wells containing all components except pri-
mary antibody, secondary antibody, or fetuin. Experi-
ments were performed twice and in triplicate. Treatment
differences were tested by student's t-test [19].
For adherence inhibition, biotinylated bacteria (1.4 × 105
cells/well) were first pretreated with specific anti-rSzP
antibodies (1:100 diluted in PBS-T) for 1 h at 37°C and
were washed before being used to infect the monolayers
as described above. Bacteria were biotinylated using the
EZ-Link Sulfo-NHS-LC-Biotinylation kit (Pierce, Rock-
ford, IL, USA) according to the manufacturer's instruc-
tions. Bacteria preincubated with normal rabbit serum
were used as controls, and wells receiving no bacteria were
used as blanks. Additional controls included wells con-
taining all ingredients except primary or secondary anti-
bodies. Binding of biotinylated bacteria to the
monolayers was detected using HRP-conjugated streptavi-
din (Pierce, Rockford, IL, USA) and a substrate chro-
mogen mixture consisting of 0.01% hydrogen peroxide in
0.1 μg/ml tetramethyl benzidine (TMB) (Sigma, St. Louis,
MO, USA). The ability of the anti-SzP mAbs to inhibit
adherence was determined as described above.
Affinity selection and panning
We used the Ph.D.-12™ phage display peptide library kit
(New England Biolabs, Bevery, MA, USA), which displays
peptide 12-mers at the N-terminus of pIII of M13 phage
with a complexity 2.7 × 109 transformants. A biopanning
protocol was employed according to the manufacturer's
instruction. Briefly, 96-well microtiter plates (Nunc,
Roskilde, Denmark) were coated with the target mAb 2C8
overnight at 4°C and were incubated with blocking solu-
tion for 1 h at 37°C. A solution containing the phage-dis-
play peptide library (1.5 × 1011 virions) was added to the
coated wells and incubated for 1 h at 37°C. Unbound
phages were removed by 10 washes with Tris-buffered
saline containing Tween-20 (TBST), bound phages were
eluted in 100 μl elution buffer [0.2 M glycine-HCl (pH
2.2), 1 mg/ml BSA], and the eluate was neutralized by the
addition of 15 μl 1 M Tris-HCl (pH 9.1). The phage out-
come was calculated by infecting ER2738 bacteria fol-
lowed by counting of transducing units (TU) on LB/IPTG/
X-gal plates. Subsequently, the phage eluates were ampli-
fied and concentrated using PEG/NaCl precipitation. Ten
microliters of amplified elute was prepared for the next
round of panning. The panning procedure of the follow-
ing four generations was similar to that of the first pan-
ning, except the Tween-20 concentration in the TBST was
increased to 0.5% (V/V) in the washing step. The number
of phages added was designated as input, the eluted
phages were designated as output, and the unbound
phages that were removed during the 10 wash steps were
designated as washing.
Specificity analysis
Sandwich ELISA was performed as follows. Wells in 96-
well microtiter plates were coated with the anti-SzP mAbs
solutions (100 μl each), which were purified from ascitic
fluids and diluted to 5 μg/ml in coating buffer (0.05 M
sodium carbonate, pH 9.7), and incubated overnight at
4°C. The wells were blocked by incubation with 200 μl 1
% BSA in PBS-T for 1 h at 37°C. After the wells were
washed three times with PBS-T, 100 μl samples of each
amplified single colony phage culture (resuspended in
PBS) were added to each well, followed by incubation for
l h at 37°C. After three washes with PBS-T, 100 μl HRP-
conjugated anti-M13 monoclonal antibody (AmershamBMC Microbiology 2008, 8:170 http://www.biomedcentral.com/1471-2180/8/170
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Pharmacia Biotech Inc, Piscatway, NJ, USA) diluted
1:2,000 in PBS-T containing 1% BSA was added to each
well, followed by incubation for 1 h at 37°C. After three
additional PBS-T washes, 100 μl of the substrate TMB was
added to each well, followed by a 10 min incubation.
Finally, 100 μl of 2 M sulfuric acid was added to each well
to stop the reaction. Relative to wells containing phages
without peptide inserts, absorbance values equal to or
greater than two-fold higher were considered positive. All
phage clones were tested in triplicate.
Competitive inhibition ELISA was performed to test the
specificity of the peptides displayed on the selected
phages. Briefly, 96-well microtiter plate wells were coated
with anti-SzP mAb (2C8) solution (1:100 diluted in PBS-
T) incubated overnight at 4°C and blocked. At the same
time, 1 × 1012 virions for each phage clone and 100 μl
purified rSzP (20 μg/ml in PBS) were mixed separately
and incubated for 30 min at 37°C. The mixtures were then
added to the wells coated with anti-SzP mAbs, followed
by incubation for l h at 37°C; positive control wells were
incubated with phages, and negative control wells were
incubated with PBS. After three washes with PBS-T, 100 μl
HRP-conjugated anti-M13 monoclonal antibody (Amer-
sham Pharmacia Biotech Inc, Piscatway, NJ, USA) diluted
1:2,000 in PBS-T containing 1% BSA was added to each
well, followed by 1 h incubation at 37°C. The subsequent
steps were performed as described above for the sandwich
ELISA. If the selected phage contained mAb-specific
epitope/mimotopes, the binding of the coated mAb with
the selected phages would be competitively inhibited by
the rSzP in solution. All phage clones were tested in tripli-
cate.
Determination of peptide sequences
Phage-containing supernatants from a single positive
clone were collected for purification of sequencing tem-
plates. PEG/NaCl (200 μl) was added to 500 μl of phage-
containing supernatant, followed by mixing and incuba-
tion at room temperature for 10 min. Following centrifu-
gation, the pellet was resuspended in 100 μl iodide buffer
[100 mM Tris-HCl (pH 8.0), 1 mM EDTA, 4 M NaI], 250
μl ethanol was added, and the resuspended pellet was
incubated for 10 min at room temperature followed by
centrifugation. The pellet was washed with 70% ethanol,
dried, and dissolved in TE buffer [10 mM Tris-HCl (pH
8.0), 1 mM EDTA]. The sequencing primer used was 5'-
CCCTCATAGTTAGCGTAACG-3'. DNA sequences were
translated into peptide sequences according to the manu-
facturer's instructions (Ph.D.-12™, New England Biolabs,
Bevery, MA, USA).
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